Cargando…
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy
BACKGROUND: To assess the long-term prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in patients with differentiated thyroid carcinoma (DTC) undergoing empiric radioiodine (RAI) therapy due to raising values of thyroglobulin (Tg). METHODS:...
Autores principales: | Salvatore, Barbara, Klain, Michele, Nicolai, Emanuele, D’Amico, Domenico, De Matteis, Gianluca, Raddi, Marco, Fonti, Rosa, Pellegrino, Teresa, Storto, Giovanni, Cuocolo, Alberto, Pace, Leonardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662418/ https://www.ncbi.nlm.nih.gov/pubmed/29049252 http://dx.doi.org/10.1097/MD.0000000000008344 |
Ejemplares similares
-
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by (18)F-FDG PET/CT: A case report
por: Giannetta, Elisa, et al.
Publicado: (2017) -
Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
por: Klain, Michele, et al.
Publicado: (2019) -
Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid Cancer
por: Piscopo, Leandra, et al.
Publicado: (2022) -
Serum thyroglobulin reference intervals in regions with adequate and more than adequate iodine intake
por: Wang, Zhaojun, et al.
Publicado: (2016) -
Strong Neck Accumulation of (131)I Is a Predictor of Incomplete Low-Dose Radioiodine Remnant Ablation Using Recombinant Human Thyroid-Stimulating Hormone
por: Enomoto, Keisuke, et al.
Publicado: (2015)